ADAM17 and cancer: These preliminary results provedthe efficacy of bifunctional inhibitors in cancer cells overexpressingADAM8, but further studies will be needed to improve the selectivityof compound 2 for ADAM8 over ADAM17 and to ultimatelydefine its mechanism of action at a molecular level.